These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 9832037)
21. Mucopolysaccharidosis type IIIB mutations in Chinese patients: identification of two novel NAGLU mutations and analysis of two cases involving prenatal diagnosis. Tang J; Pan J; Guo Y; Ai Y; Jiang W; Du M; Fang Q Clin Chim Acta; 2013 Apr; 419():33-8. PubMed ID: 23380547 [TBL] [Abstract][Full Text] [Related]
23. Mucopolysaccharidosis IIIB and mild skeletal anomalies: coexistence of NAGLU and CYP26B1 missense variations in the same patient in a Chinese family. Li J; Xie H; Jiang Y BMC Med Genet; 2018 Apr; 19(1):51. PubMed ID: 29606097 [TBL] [Abstract][Full Text] [Related]
24. Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain. Gografe SI; Garbuzova-Davis S; Willing AE; Haas K; Chamizo W; Sanberg PR Comp Med; 2003 Dec; 53(6):622-32. PubMed ID: 14727810 [TBL] [Abstract][Full Text] [Related]
25. Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome. Kan SH; Elsharkawi I; Le SQ; Prill H; Mangini L; Cooper JD; Lawrence R; Sands MS; Crawford BE; Dickson PI Mol Genet Metab; 2021 Jun; 133(2):185-192. PubMed ID: 33839004 [TBL] [Abstract][Full Text] [Related]
26. Processing of mutant N-acetyl-α-glucosaminidase in mucopolysaccharidosis type IIIB fibroblasts cultured at low temperature. Meijer OLM; Te Brinke H; Ofman R; IJlst L; Wijburg FA; van Vlies N Mol Genet Metab; 2017 Sep; 122(1-2):100-106. PubMed ID: 28751108 [TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of the alpha-N-acetylglucosaminidase gene in seven Japanese patients from six unrelated families with mucopolysaccharidosis IIIB (Sanfilippo type B), including two novel mutations. Tanaka A; Kimura M; Lan HT; Takaura N; Yamano T J Hum Genet; 2002; 47(9):484-7. PubMed ID: 12202988 [TBL] [Abstract][Full Text] [Related]
28. Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells. Huang W; Cheng YS; Yang S; Swaroop M; Xu M; Huang W; Zheng W Exp Cell Res; 2021 Oct; 407(1):112785. PubMed ID: 34411609 [TBL] [Abstract][Full Text] [Related]
29. Treatment of the mouse model of mucopolysaccharidosis type IIIB with lentiviral-NAGLU vector. Di Natale P; Di Domenico C; Gargiulo N; Castaldo S; Gonzalez Y Reyero E; Mithbaokar P; De Felice M; Follenzi A; Naldini L; Villani GR Biochem J; 2005 Jun; 388(Pt 2):639-46. PubMed ID: 15649123 [TBL] [Abstract][Full Text] [Related]
30. Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer. Villani GR; Follenzi A; Vanacore B; Di Domenico C; Naldini L; Di Natale P Biochem J; 2002 Jun; 364(Pt 3):747-53. PubMed ID: 12049639 [TBL] [Abstract][Full Text] [Related]
31. Utilizing ExAC to assess the hidden contribution of variants of unknown significance to Sanfilippo Type B incidence. Clark WT; Yu GK; Aoyagi-Scharber M; LeBowitz JH PLoS One; 2018; 13(7):e0200008. PubMed ID: 29979746 [TBL] [Abstract][Full Text] [Related]
32. A novel mutation (c.200T>C) in the NAGLU gene of a Korean patient with mucopolysaccharidosis IIIB. Kim YE; Park HD; Jang MA; Ki CS; Lee SY; Kim JW; Cho SY; Jin DK Ann Lab Med; 2013 May; 33(3):221-4. PubMed ID: 23667853 [TBL] [Abstract][Full Text] [Related]
33. Structural characterization of the α-N-acetylglucosaminidase, a key enzyme in the pathogenesis of Sanfilippo syndrome B. Birrane G; Dassier AL; Romashko A; Lundberg D; Holmes K; Cottle T; Norton AW; Zhang B; Concino MF; Meiyappan M J Struct Biol; 2019 Mar; 205(3):65-71. PubMed ID: 30802506 [TBL] [Abstract][Full Text] [Related]
34. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. Cressant A; Desmaris N; Verot L; Bréjot T; Froissart R; Vanier MT; Maire I; Heard JM J Neurosci; 2004 Nov; 24(45):10229-39. PubMed ID: 15537895 [TBL] [Abstract][Full Text] [Related]
35. Update of the spectrum of mucopolysaccharidoses type III in Tunisia: identification of three novel mutations and in silico structural analysis of the missense mutations. Ouesleti S; Coutinho MF; Ribeiro I; Miled A; Mosbahi DS; Alves S World J Pediatr; 2017 Aug; 13(4):374-380. PubMed ID: 28101780 [TBL] [Abstract][Full Text] [Related]
36. Sanfilippo syndrome type C: mutation spectrum in the heparan sulfate acetyl-CoA: alpha-glucosaminide N-acetyltransferase (HGSNAT) gene. Feldhammer M; Durand S; Mrázová L; Boucher RM; Laframboise R; Steinfeld R; Wraith JE; Michelakakis H; van Diggelen OP; Hrebícek M; Kmoch S; Pshezhetsky AV Hum Mutat; 2009 Jun; 30(6):918-25. PubMed ID: 19479962 [TBL] [Abstract][Full Text] [Related]
37. Identification of Orthosteric and Allosteric Pharmacological Chaperones for Mucopolysaccharidosis Type IIIB. Losada JC; Triana H; Vanegas E; Caro A; Rodríguez-López A; Espejo-Mojica AJ; Alméciga-Diaz CJ Chembiochem; 2024 Aug; 25(15):e202400081. PubMed ID: 38830828 [TBL] [Abstract][Full Text] [Related]
38. Residual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB. Meijer OLM; Welling L; Valstar MJ; Hoefsloot LH; Brüggenwirth HT; van der Ploeg AT; Ruijter GJG; Wagemans T; Wijburg FA; van Vlies N J Inherit Metab Dis; 2016 May; 39(3):437-445. PubMed ID: 26907177 [TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of the HGSNAT gene in Italian patients with mucopolysaccharidosis IIIC (Sanfilippo C syndrome). Mutation in brief #959. Online. Fedele AO; Filocamo M; Di Rocco M; Sersale G; Lübke T; di Natale P; Cosma MP; Ballabio A Hum Mutat; 2007 May; 28(5):523. PubMed ID: 17397050 [TBL] [Abstract][Full Text] [Related]
40. Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency. Lotfi P; Tse DY; Di Ronza A; Seymour ML; Martano G; Cooper JD; Pereira FA; Passafaro M; Wu SM; Sardiello M Autophagy; 2018; 14(8):1419-1434. PubMed ID: 29916295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]